Success Stories: Thanks to PP, a Stroke and Interventional Neurologist from India Got an EB-1A Approval in Just 9 Days

 

Client’s Testimonial:

“I would like to thank you again for all the hard-work you put in to my case that lead to positive outcome.”


On July 16th, 2021, we received another EB-1A (Alien of Extraordinary Ability) approval for a Stroke and Interventional Neurologist in the field of Neurology (Approval Notice).


General Field: Neurology

Position at the Time of Case Filing: Stroke and Interventional Neurologist

Country of Origin: India

State of Residence at the Time of Filing: North Carolina

Approval Notice Date: July 16th, 2021

Processing Time: 9 days (Premium Processing Requested)


Case Summary:

An M.B.B.S. neurologist from India approached NAILG (North American Immigration Law Group) to help him petition for EB-1A (Alien of Extraordinary Ability) at USCIS. Having confirmed his credentials we went on to countersign the retainer agreement. We made use of exclusive PP (Premium Processing) due to our client’s request to expedite his case. With no less than 25,000+ case approvals we were able to help him in every way possible during the entire process of adjudication. We took care to personalize his Petition Letter and include the following few things in it:

  • We noted that his works had been cited a massive 998 times by dependent and independent researchers. This indicated the major significance of his findings to others in his field around the world.
  • We also detailed the 33 peer-reviewed scientific articles and 3 book chapters, all of which appeared in well-known journals.
  • Further, we found that our client has assessed the work of his fellow peers some 33 times. As only the best in the field are invited to judge the work of others, our client’s notable peer review record spoke volumes of his respected status as an extraordinary researcher.
  • Furthermore, our client’s work has been cited by researchers from 51 countries around the world. He is also one of the top 1% most highly cited authors publishing on topics in neurology over the past 10 years according to Microsoft Academic. It can therefore be objectively corroborated that he has made significant original contributions documented by his publications, as his achievements have been widely recognized and relied upon in the field of neurology and other allied fields too.
  • Arguably one of the most important elements of our client’s EB1A petition dossier was related to his research on improving, developing, and conducting medical trials. His work on the applications of clopidogrel and aspirin in treating high-risk transient ischemic attack (TIA) and preventing acute ischemic stroke in a clinical setting is groundbreaking. His work drove improvements in endovascular surgical neuroradiology, interventional neurology, vascular neurology, internal medicine, and neurology. His unique and expansive expertise has enabled him to contribute significantly to the field of neurology, extending the reasonable expectation that he will continue to do so within the United States.
  • To further fortify our client’s petition, we included 4 recommendation letters signed by several dependent and independent experts in the field, one of whom stated that:
“With his consistent record of success and accomplishment in neurology and the treatment of cerebrovascular disorders, I feel that it is essential that [client] be allowed to continue his exemplary work in the U.S., and it is more than reasonable to expect additional innovations from him in the future.”

We are pleased that our hard work paid off and that our client is now one big step closer to green card success. We thank him for choosing us to represent his EB1A case and we wish him the best as he continues to advance the field of neurology.